Correlation Between Willamette Valley and Avadel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Willamette Valley and Avadel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Willamette Valley and Avadel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Willamette Valley Vineyards and Avadel Pharmaceuticals PLC, you can compare the effects of market volatilities on Willamette Valley and Avadel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Willamette Valley with a short position of Avadel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Willamette Valley and Avadel Pharmaceuticals.
Diversification Opportunities for Willamette Valley and Avadel Pharmaceuticals
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Willamette and Avadel is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Willamette Valley Vineyards and Avadel Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avadel Pharmaceuticals and Willamette Valley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Willamette Valley Vineyards are associated (or correlated) with Avadel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avadel Pharmaceuticals has no effect on the direction of Willamette Valley i.e., Willamette Valley and Avadel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Willamette Valley and Avadel Pharmaceuticals
Given the investment horizon of 90 days Willamette Valley Vineyards is expected to generate 0.27 times more return on investment than Avadel Pharmaceuticals. However, Willamette Valley Vineyards is 3.66 times less risky than Avadel Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. Avadel Pharmaceuticals PLC is currently generating about -0.11 per unit of risk. If you would invest 337.00 in Willamette Valley Vineyards on September 14, 2024 and sell it today you would lose (8.00) from holding Willamette Valley Vineyards or give up 2.37% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Willamette Valley Vineyards vs. Avadel Pharmaceuticals PLC
Performance |
Timeline |
Willamette Valley |
Avadel Pharmaceuticals |
Willamette Valley and Avadel Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Willamette Valley and Avadel Pharmaceuticals
The main advantage of trading using opposite Willamette Valley and Avadel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Willamette Valley position performs unexpectedly, Avadel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will offset losses from the drop in Avadel Pharmaceuticals' long position.Willamette Valley vs. Naked Wines plc | Willamette Valley vs. Andrew Peller Limited | Willamette Valley vs. Iconic Brands | Willamette Valley vs. Naked Wines plc |
Avadel Pharmaceuticals vs. Neurocrine Biosciences | Avadel Pharmaceuticals vs. Ironwood Pharmaceuticals | Avadel Pharmaceuticals vs. Alkermes Plc | Avadel Pharmaceuticals vs. Intracellular Th |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |